Highlights
NASDAQ: GENE       Genetic Tech Spn Ads
Last Price Today's Change   Day's Range   Trading Volume
4.43   +0.10 (2.31%)  4.221 - 4.65  41,760

Overview

 
Avg Volume (4 weeks):1,864,005
4 Weeks Range:1.90 - 5.36
4 Weeks Price Volatility (%):
73.12%
52 Weeks Range:0.52 - 5.36
52 Weeks Price Volatility (%):
80.79%
Average Price Target: 7.50
Price Target Upside/Downside: +3.07

Headlines



No recent Headlines for this stock.


Business Background

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women’s health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company’s revenue is generated from Australia and United States.

  Be the first to like this.
 


 

3281  2252  464  2965 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 PFE 38.58-1.58 
 VXRT 0.853+0.21 
 NIO 4.13+0.12 
 BBT 54.24+0.75 
Partners & Brokers